Drug Profile
Interferon alpha controlled-release - Delpor
Alternative Names: DLP-201; IFN-alpha - DelporLatest Information Update: 15 Sep 2023
Price :
$50
*
At a glance
- Originator Delpor
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Hepatitis C
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 15 Sep 2023 Discontinued - Preclinical for Hepatitis C in USA (SC)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Hepatitis-C in USA (SC, Implant)
- 15 Aug 2016 Interferon alpha controlled-release - Delpor is available for licensing as of 15 Aug 2016. http://www.delpor.com/